<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>ClinicalTrials.gov: covid-19 | Last update posted in the last 2 days</title>
    <link>https://clinicaltrials.gov/ct2/results/rss.xml?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2&amp;amp;count=1000</link>
    <description>Studies found on ClinicalTrials.gov by a search of: covid-19 | Last update posted in the last 2 days</description>
    <language>en-us</language>
    <pubDate>Sun, 21 Feb 2021 10:18:50 EST</pubDate>
    <ttl>1440</ttl>
    <item>
      <title>Safety and Efficacy of C21 in Subjects With COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04452435?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: C21;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Vicore Pharma AB;   Orphan Reach&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04452435</guid>
      <pubDate>Tue, 30 Jun 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04425629?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: REGN10933+REGN10987 combination therapy;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Regeneron Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04425629</guid>
      <pubDate>Thu, 11 Jun 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04495101?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Prolastin;   Drug: Standard Medical Treatment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Instituto Grifols, S.A.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04495101</guid>
      <pubDate>Fri, 31 Jul 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Favipiravir Therapy in Adults With Mild COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04464408?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Favipiravir;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    King Abdullah International Medical Research Center;   Ministry of Health, Saudi Arabia&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04464408</guid>
      <pubDate>Thu, 09 Jul 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Protecting Native Families From COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04765475?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Motivational Interviewing;   Behavioral: COVID-19 Symptom Monitoring System;   Behavioral: Motivational Interviewing and COVID-19 Symptom Monitoring System;   Other: Supportive Services&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Johns Hopkins Bloomberg School of Public Health&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04765475</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04583969?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Lenzilumab;   Other: Placebo;   Drug: Remdesivir&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04583969</guid>
      <pubDate>Mon, 12 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Longitudinal Study of COVID-19 Sequelae and Immunity</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04411147?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04411147</guid>
      <pubDate>Tue, 02 Jun 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04583956?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Placebo;   Drug: Remdesivir;   Biological: Risankizumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04583956</guid>
      <pubDate>Mon, 12 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04394884?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04394884</guid>
      <pubDate>Wed, 20 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Atovaquone for Treatment of COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04456153?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Experimental Group;   Drug: Placebo Group&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Texas Southwestern Medical Center&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04456153</guid>
      <pubDate>Thu, 02 Jul 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04591717?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: hAd5-S-Fusion+N-ETSD vaccine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    ImmunityBio, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04591717</guid>
      <pubDate>Mon, 19 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04483635?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: Placebo;   Dietary Supplement: Vitamin D&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    St. Justine's Hospital;   Canadian Institutes of Health Research (CIHR);   Laboratoire RIVA&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04483635</guid>
      <pubDate>Thu, 23 Jul 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04701658?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Bamlanivimab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Eli Lilly and Company;   AbCellera Biologics Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04701658</guid>
      <pubDate>Fri, 08 Jan 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04501952?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: RDV;   Drug: Placebo to Match RDV&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Gilead Sciences&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04501952</guid>
      <pubDate>Thu, 06 Aug 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04539262?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Remdesivir (RDV);   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Gilead Sciences&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04539262</guid>
      <pubDate>Fri, 04 Sep 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04582903?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19 Infection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04582903</guid>
      <pubDate>Mon, 12 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Adoptive SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04762186?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Moderate COVID-19-infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: IMP 1,000 plus SoC;   Drug: IMP 5,000 plus SoC;   Drug: IMP RP2D plus SoC;   Drug: SoC&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    UniversitÃ¤tsklinikum KÃ¶ln;   ZKS KÃ¶ln;   MMH Institute for Transfusion Medicine;   Miltenyi Biomedicine GmbH&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04762186</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04478019?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    COVID-19;   SARS-CoV 2&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: 10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Wisconsin, Madison&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04478019</guid>
      <pubDate>Mon, 20 Jul 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Intravenous Infusion of CAP-1002 in Patients With COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04623671?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: CAP-1002;   Biological: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Capricor Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04623671</guid>
      <pubDate>Tue, 10 Nov 2020 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Genetics of COVID-19 Susceptibility and Manifestations</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04371432?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    COVID-19;   Coronavirus 2019&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Human Genome Research Institute (NHGRI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04371432</guid>
      <pubDate>Fri, 01 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04600141?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Tocilizumab;   Drug: Heparin - Therapeutic dosage;   Drug: Heparin - Prophylactic dosage&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Sao Paulo;   Conselho Nacional de Desenvolvimento CientÃ­fico e TecnolÃ³gico&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04600141</guid>
      <pubDate>Fri, 23 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04565067?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute on Aging (NIA)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04565067</guid>
      <pubDate>Fri, 25 Sep 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04625257?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronavirus Infectious Disease 2019 (COVID-19)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Saliva based assay: crude RNA extraction;   Other: Validation of the NGS method;   Other: Validation of the LAMP assays;   Other: Validation of the POCT Antigen and Antibody tests&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University Hospital, Basel, Switzerland;   ETH Zurich Department for Biosystems, Science and Engineering;   Kanton Basel- Landschaft&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04625257</guid>
      <pubDate>Thu, 12 Nov 2020 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04575584?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronavirus Disease (COVID-19)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Molnupiravir;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04575584</guid>
      <pubDate>Mon, 05 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04575597?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronavirus Disease (COVID-19)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Molnupiravir;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04575597</guid>
      <pubDate>Mon, 05 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>TD-0903 for ALI Associated With COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04402866?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Acute Lung Injury (ALI) Associated With COVID-19;   Lung Inflammation Associated With COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: TD-0903;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Theravance Biopharma&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04402866</guid>
      <pubDate>Wed, 27 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Tafenoquine in Patients With Mild to Moderate COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04533347?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID 19 Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Tafenoquine Oral Tablet;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    60 Degrees Pharmaceuticals LLC&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04533347</guid>
      <pubDate>Mon, 31 Aug 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Recombinant Protein Vaccine With Adjuvant Against COVID-19 in Adults 18 Years of Age and Older</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04762680?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19 (Healthy Volunteers)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: SARS-CoV-2 recombinant protein vaccine Formulation 1;   Biological: SARS-CoV-2 recombinant protein vaccine Formulation 2;   Biological: SARS-CoV-2 recombinant protein vaccine Formulation 3&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Sanofi Pasteur, a Sanofi Company;   GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04762680</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04762628?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: MAF capsules 148 mg;   Dietary Supplement: M capsules 148 mg;   Other: Standard of care&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Saisei Pharma&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04762628</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04723537?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Part A: Upamostat 200 mg;   Drug: Part A: Upamostat 400 mg;   Drug: Part A and B: Placebo;   Drug: Part B: Upamostat 200 or 400 mg&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    RedHill Biopharma Limited&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04723537</guid>
      <pubDate>Mon, 25 Jan 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04764747?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Kufa University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04764747</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04765449?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Cytotoxic T Lymphocytes&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Thomas Jefferson University;   Tevogen Bio Inc&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04765449</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>CardioVascular Disease Progression and Prognosis in COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04606732?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Bologna&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04606732</guid>
      <pubDate>Wed, 28 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04734873?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: CPI-006 2 mg/kg + SOC;   Drug: CPI-006 1 mg/kg + SOC;   Drug: Placebo + SOC&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Corvus Pharmaceuticals, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04734873</guid>
      <pubDate>Tue, 02 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04732637?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Diagnostic Test: Test At Home's Proprietary &quot;Lollipop&quot; Buccal Cavity Swab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Datar Cancer Genetics Limited;   Test At Home;   National University, Singapore&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04732637</guid>
      <pubDate>Mon, 01 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04765436?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19 Vaccine&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: PTX-COVID19-B;   Biological: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Providence Therapeutics Holdings Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04765436</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04397614?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Sars-CoV2;   Covid-19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: mHealth Assessments&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Oklahoma&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04397614</guid>
      <pubDate>Thu, 21 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04764721?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid-19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: 18F-FDG PET-CT&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Central Hospital, Nancy, France&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04764721</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>CPAx for Assessing Functional Status of COVID-19 Patients After Intensive Care Unit Discharge</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04762056?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Post Intensive Care Unit Syndrome;   Covid19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Chelsea Critical Care Physical Assessment Tool&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Gaziosmanpasa Taksim Research and Education Hospital&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04762056</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04642638?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Coronavirus Infection;   Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2);   COVID-19 Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: INO-4800;   Device: CELLECTRAÂ® 2000;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Inovio Pharmaceuticals&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04642638</guid>
      <pubDate>Tue, 24 Nov 2020 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Description of the Population With Genitourinary Tumors and COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04578132?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   Genito Urinary Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Spanish Oncology Genito-Urinary Group&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04578132</guid>
      <pubDate>Thu, 08 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04565080?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Parkinson's Disease;   Functional Movement Disorders;   COVID-19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Neurological Disorders and Stroke (NINDS)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04565080</guid>
      <pubDate>Fri, 25 Sep 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Covid-19 Epidemic Lockdown Impact on Psychomotor Performance</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04761718?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19 Epidemic Lockdown Impact&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Delta University for Science and Technology&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04761718</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study of Immune Responses to the Virus That Causes COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04431414?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    SARS-CoV-2;   COVID-19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Sample collection&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    COVID-19 Prevention Network;   National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04431414</guid>
      <pubDate>Tue, 16 Jun 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to DEX in Patients With COVID-19 Pneumonia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04561180?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pneumonia as One of the Lung Complications Caused by SARS-CoV-2 Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: EG-HPCP-03a;   Drug: EG-HPCP-03a Placebo;   Drug: Standard of Care;   Drug: Dexamethasone&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Evergreen Therapeutics, Inc.&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04561180</guid>
      <pubDate>Wed, 23 Sep 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04741061?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19 Prevention&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Sputnik Light;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation;   RDIF (Russian Direct Investment Fund);   CRO: iPharma;   Government of the city of Moscow&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04741061</guid>
      <pubDate>Fri, 05 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>NCI COVID-19 in Cancer Patients, NCCAPS Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04387656?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    COVID-19 Infection;   Hematopoietic and Lymphoid Cell Neoplasm;   Malignant Solid Neoplasm;   Metastatic Malignant Solid Neoplasm&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Biospecimen Collection;   Other: Data Collection;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04387656</guid>
      <pubDate>Thu, 14 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04395456?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: AMY-101;   Other: WFI 5% glucose&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amyndas Pharmaceuticals S.A.&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04395456</guid>
      <pubDate>Wed, 20 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Outpatient Treatment of COVID-19 With Metformin</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04510194?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   SARS-CoV Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Metformin;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Minnesota;   UnitedHealth Group;   Northwestern University;   Hennepin County Medical Center, Minneapolis;   University of Colorado, Denver;   Olive View-UCLA Education &amp; Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04510194</guid>
      <pubDate>Wed, 12 Aug 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04716569?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: intranasal ivermectin spray&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    South Valley University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04716569</guid>
      <pubDate>Wed, 20 Jan 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Colchicine vs Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04510038?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   Myocardial Injury&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Colchicine;   Other: Covid-19 Standard of Care&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Miami Cardiac and Vascular Institute;   University of California, Los Angeles&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04510038</guid>
      <pubDate>Wed, 12 Aug 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Nasal Poly-ICLC (HiltonolÂ®) for Prophylaxis of COVID-19 in Healthy Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04672291?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID - 19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Poly-ICLC (HiltonolÂ®)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Oncovir, Inc.;   University of Calgary&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04672291</guid>
      <pubDate>Thu, 17 Dec 2020 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Use of Convalescent Plasma for COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04408040?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Convalescent Plasma&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Northside Hospital, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04408040</guid>
      <pubDate>Fri, 29 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Registry of Sustained Immunity to COVID-19 Among ESKD Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04495764?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    SARS-CoV-2 Infection;   Anti-SARS-CoV-2 Infection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Davita Clinical Research&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04495764</guid>
      <pubDate>Mon, 03 Aug 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04405570?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    SARS-CoV 2&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: EIDD-2801;   Drug: Placebo (PBO)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ridgeback Biotherapeutics, LP&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04405570</guid>
      <pubDate>Thu, 28 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Right Ventricular Dysfunction in Ventilated Patients With COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04764032?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   Right Ventricular Dysfunction;   ARDS&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Diagnostic Test: Echocardiography&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Glasgow;   Golden Jubilee National Hospital;   Robertson Centre for Biostatistics&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04764032</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04762771?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Covid19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Colchicine&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Baptist Health South Florida;   University of California, Los Angeles&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04762771</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Clinical Trial of a Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04591184?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    SARS-CoV-2&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Covigenix VAX-001 placebo;   Biological: Covigenix VAX-001&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Entos Pharmaceuticals Inc.;   Canadian Institutes of Health Research (CIHR)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04591184</guid>
      <pubDate>Mon, 19 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04588363?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2);   Multisystem Inflammatory Syndrome in Children (MIS-C);   Coronavirus Disease 2019 (COVID-19)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: SARS-CoV-2 and/or MIS-C Exposure&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID);   Autoimmunity Centers of Excellence;   Clinical Trials in Organ Transplantation in Children&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04588363</guid>
      <pubDate>Mon, 19 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Paediatric Inflammatory Multisystem Syndrome During COVID-19 Pandemic</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04761913?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-Cov-2&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Anglia Ruskin University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04761913</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04756466?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    SARS CoV-2 Infection;   Elderly&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: Placebo;   Dietary Supplement: Lactobacillus&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Biosearch S.A.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04756466</guid>
      <pubDate>Tue, 16 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>COVID-19 Infection in Diabetic Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04765254?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   Diabete Type 2;   Non Diabetic Patients;   Chest CT Scan&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: no intervention as it is an observational study&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cairo University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04765254</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>SARS-COV2 Pandemic Serosurvey in a Rare Disease Population</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04609085?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    SARS-COV2 Virus&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04609085</guid>
      <pubDate>Fri, 30 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04334148?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Hydroxychloroquine;   Drug: Placebo oral tablet&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Adrian Hernandez;   Patient-Centered Outcomes Research Institute&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04334148</guid>
      <pubDate>Mon, 06 Apr 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>SARS-COV2 Pandemic Serosurvey and Blood Sampling</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04334954?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    SARS-COV2 Virus&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04334954</guid>
      <pubDate>Mon, 06 Apr 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04760821?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Acute Respiratory Distress Syndrome;   Covid19;   Myocardial Injury&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Trimetazidine&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Ministry of Health, Brazil;   InCor Heart Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04760821</guid>
      <pubDate>Thu, 18 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Cross Sectional CFAR HIV/COVID-19 Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04514016?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    SARS-CoV Infection;   Covid19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Miami&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04514016</guid>
      <pubDate>Fri, 14 Aug 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04764981?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   SARS-CoV Infection;   Olfactory Disorder;   Anosmia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Essence oils&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Universidade do Estado do ParÃ¡&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04764981</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04405739?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    SARS-CoV 2&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: EIDD-2801;   Drug: Placebo (PB0)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ridgeback Biotherapeutics, LP&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04405739</guid>
      <pubDate>Thu, 28 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04689399?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   Rapid Antigen Test;   SARS-CoV-2&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Diagnostic Test: Standard Q COVID-19 Ag - test, produced by SD Biosensor INC.&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Rigshospitalet, Denmark;   Testcenter Danmark, Statens Serum Institut;   Copenhagen Emergency Medical Services&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04689399</guid>
      <pubDate>Wed, 30 Dec 2020 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Influence Physical Activity Psychological Responses COVID-19 Pandemic</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04352517?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Sedentary Behavior;   Mental Health Wellness 1&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Online Survey&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Extremadura&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04352517</guid>
      <pubDate>Mon, 20 Apr 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Inhaled Aviptadil for the Treatment of Moderate and Severe COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04360096?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    SARS-CoV 2;   COVID;   ARDS;   ALI;   Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS);   Dyspnea&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: RLF-100 (aviptadil);   Drug: Placebo;   Device: Nebulized administration of RLF-100 or Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    NeuroRx, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04360096</guid>
      <pubDate>Fri, 24 Apr 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Liver Function Test Abnormalities in COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04763395?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Liver Function Tests Abnormalities&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: No intervention&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Sohag University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04763395</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Persistence of Symptoms After Improvement of Acute COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04764773?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Corona Virus Infection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: No intervention&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Sohag University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04764773</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04715932?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   Anosmia;   Fever;   Cough;   Shortness of Breath;   Sore Throat;   Nausea;   Vomiting;   Headache;   Muscle Weakness;   Pain, Muscle;   Pain, Chest;   Pain, Joint;   Pain, Abdominal;   Pain;   Irritable Mood;   Confusion&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Hesperidin;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Montreal Heart Institute;   Ingenew Pharmaceuticals Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04715932</guid>
      <pubDate>Wed, 20 Jan 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT03808922?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lower Respiratory Tract Infection;   Parainfluenza;   Immunocompromised;   COVID-19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: DAS181;   Drug: Placebo;   Drug: DAS181 COVID-19;   Drug: DAS181 OL&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ansun Biopharma, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT03808922</guid>
      <pubDate>Fri, 18 Jan 2019 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04391816?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Alcohol Drinking;   Alcohol-Related Disorders;   Pandemic;   Psychological Stress&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute on Alcohol Abuse and Alcoholism (NIAAA)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04391816</guid>
      <pubDate>Mon, 18 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Self-Help for Stress Related to COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04762173?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Stress&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Online self-help intervention&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Penn State University&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04762173</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04636554?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   Bacteremia;   Septicemia;   Acinetobacter Baumannii Infection;   Pseudomonas Aeruginosa Infection;   Staph Aureus Infection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Phage Therapy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Adaptive Phage Therapeutics, Inc.&lt;br/&gt;&lt;b&gt;Available&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04636554</guid>
      <pubDate>Thu, 19 Nov 2020 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04339790?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Healthy Volunteer;   Mood Disorder;   Anxiety Disorder;   Preexisting Medical Condition&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Mental Health (NIMH)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04339790</guid>
      <pubDate>Thu, 09 Apr 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04761692?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   Influenza;   Pneumonia;   Vaccine Refusal&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Full VEPMP Intervention;   Behavioral: Partial VEPMP Intervention;   Behavioral: Delayed VEPMP Intervention&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Charles Drew University of Medicine and Science&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04761692</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04761874?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Stroke, Acute&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Telestroke&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Minnesota&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04761874</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in HealthyVolunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04594395?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy Volunteers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04594395</guid>
      <pubDate>Tue, 20 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Living With Sickle Cell Disease in the COVID-19 Pandemic</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04417673?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Isolation;   Anxiety;   Health Care Utilization;   Sickle Cell Disease;   Pain&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Human Genome Research Institute (NHGRI)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04417673</guid>
      <pubDate>Fri, 05 Jun 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Improving Activity Engagement Among Persons With SCI During COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04408287?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Spinal Cord Injuries&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: WebEx Physical Activity Program&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Lawson Health Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04408287</guid>
      <pubDate>Fri, 29 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04377100?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Anxiety;   Healthy Volunteers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Computer task questionnaires&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Mental Health (NIMH)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04377100</guid>
      <pubDate>Wed, 06 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04684615?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Depression;   Anxiety;   Bipolar Disorder&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Mental Health (NIMH)&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04684615</guid>
      <pubDate>Thu, 24 Dec 2020 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Digital Acoustic Surveillance for Early Detection of Respiratory Disease Outbreaks</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04762693?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid19;   Cough&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Hyfe cough tracker&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Clinica Universidad de Navarra, Universidad de Navarra;   Centre de Recherche du Centre Hospitalier de l'UniversitÃ© de MontrÃ©al&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04762693</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04395430?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Pediatric Obesity;   Clinical Trial&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Usual Care;   Behavioral: online KKH Sports Singapore Program with Usual Care&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    KK Women's and Children's Hospital;   Duke University;   Duke-NUS Graduate Medical School;   Sport Singapore;   Health Promotion Board, Singapore&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04395430</guid>
      <pubDate>Wed, 20 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04765371?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronavirus Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: DEXAMETHASONE;   Drug: PREDNISOLONE&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier RenÃ© Dubos&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04765371</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04367636?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Rumination;   Anxiety;   Stress;   Depressive Symptoms&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Behavioral: OCAT-sham;   Behavioral: Behavioral: OCAT;   Other: psycho-education video&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Ghent&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04367636</guid>
      <pubDate>Wed, 29 Apr 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>SARS Vaccination Reactions</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04761822?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    SARS-CoV Infection;   COVID-19;   Allergic Reaction;   Mast Cell Disorder;   Non-atopic&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Moderna COVID-19 Vaccine;   Biological: Pfizer-BioNTech COVID-19 Vaccine;   Biological: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN);   Rho Federal Systems Division, Inc.&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04761822</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04754698?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Rheumatic Disease;   HIV Infections;   AIDS;   Safety Issues;   Immunogenicity;   COVID-19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: CoronaVac&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Sao Paulo General Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04754698</guid>
      <pubDate>Mon, 15 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04374474?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Olfactory Disorder&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Olfactory retraining;   Drug: corticosteroid nasal irrigation;   Other: smell household Items;   Other: Nasal Irrigation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Lawson Health Research Institute&lt;br/&gt;&lt;b&gt;Withdrawn&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04374474</guid>
      <pubDate>Tue, 05 May 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Immunogenicity of Inactivated Vaccine Against COVID-19 Infection</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04756271?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Vaccine Adverse Reaction;   Seroconversion&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: SARS-Cov-2 neutralizing antibody titer&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Zagazig University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04756271</guid>
      <pubDate>Tue, 16 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Maternal Telemental Health Interventions in Response to Covid-19*</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04594525?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Perinatal Depression;   Specific Phobia;   Perinatal Anxiety&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Low-Intensity Psychosocial Interventions through Telemental health&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hamad Medical Corporation&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04594525</guid>
      <pubDate>Tue, 20 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04419870?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Mitochondrial Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Human Genome Research Institute (NHGRI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04419870</guid>
      <pubDate>Tue, 09 Jun 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The COVID-19 ICU PRAYER Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04361838?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronavirus Infection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: prayer&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Kansas City Heart Rhythm Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04361838</guid>
      <pubDate>Fri, 24 Apr 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>COV2Base-A Rare Disease by COVID Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04564274?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Chronic Health Conditions;   Older Age is Associated With Increased Pathogenicity&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04564274</guid>
      <pubDate>Fri, 25 Sep 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Effect of Behaviour Change Interventions on Use of Public Handwashing Stations in Bangladesh</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04765540?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hand Washing;   Handwashing;   Covid19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Low Intensity Nudges;   Behavioral: High Intensity Activities;   Behavioral: BRAC's business-as-usual&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    The Behavioural Insights Team;   Brac;   BRAC Institute of Governance and Development;   Unilever U.K. Central Resources Limited;   D2 Technologies Ltd, Bangladesh;   Foreign, Commonwealth and Development Office, U.K.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04765540</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04764422?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Covid-19;   SARS Pneumonia;   Pneumonia, Viral;   Covid19&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Normal Saline;   Biological: NDV-HXP-S vaccine&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Mahidol University;   The Government Pharmaceutical Organization&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04764422</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04765384?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Ad26.COV2.S;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Janssen Vaccines &amp; Prevention B.V.&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04765384</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04715854?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hypoxemic Respiratory Failure;   Emergencies;   Covid19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Mask&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Laboratory of Movement, Condorcet, Tournai, Belgium&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04715854</guid>
      <pubDate>Wed, 20 Jan 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Couple HOPES (Helping Overcome PTSD and Enhance Satisfaction)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04763681?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Posttraumatic Stress Disorder&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Couple HOPES Guided, Internet-Delivered, Self-Help Intervention&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    York University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04763681</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04426071?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Brain Injuries;   Stroke;   Spinal Cord Injuries&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Lawson Health Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04426071</guid>
      <pubDate>Thu, 11 Jun 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>New Predictors in Determining the Need for Invasive Treatment in Non-STEMI</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04763213?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Myocard Infarctus&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Diagnostic Test: Coronary Angiography&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Kahramanmaras Sutcu Imam University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04763213</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04657809?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anosmia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Combination Product: Insulin film;   Device: Fast dissolving film&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Soad Ali;   Minia University&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04657809</guid>
      <pubDate>Tue, 08 Dec 2020 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04765215?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: CoronoVAC&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Asoc. Prof. ErdoÄŸan SelÃ§uk Åžeber&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04765215</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04573062?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Post-Coronavirus Disease 19&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Neurological Disorders and Stroke (NINDS)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04573062</guid>
      <pubDate>Mon, 05 Oct 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>ICBT for Mental Health Problems Related to the Coronavirus Pandemic</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04424212?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Depression and Quality of Life Related to the Coronavirus Pandemic&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Intervention group CoronaCope&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Linkoeping University&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04424212</guid>
      <pubDate>Tue, 09 Jun 2020 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04240886?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Invasive Fungal Infections&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: fosmanogepix&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amplyx Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04240886</guid>
      <pubDate>Mon, 27 Jan 2020 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Self-contamination Following Removal of Two Personal Protective Equipment Suits: a Crossover Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04763304?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Personal Protective Equipment;   Self Contamination&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Gown personal protective equipment (PPE-G) suit;   Other: Coverall personal protective equipment (PPE-C) suit&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hospital Italiano de Buenos Aires&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04763304</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Mindfulness-SOS: Stress Reduction for Refugees</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT04761510?cond=covid-19&amp;amp;lupd_s=02%2F20%2F2021&amp;amp;lupd_d=2</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stress Disorders, Post-Traumatic;   Stress Related Disorder&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Mindfulness-SOS for Refugees&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Haifa&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT04761510</guid>
      <pubDate>Sun, 21 Feb 2021 12:00:00 EST</pubDate>
    </item>
  </channel>
</rss>